Global Market Bulletin
  • Home
  • Stock Market News
  • Investing
  • Economy
  • CEO Interviews
  • Contact Us
No Result
View All Result
SUBSCRIBE
Global Market Bulletin
  • Home
  • Stock Market News
  • Investing
  • Economy
  • CEO Interviews
  • Contact Us
No Result
View All Result
Global Market Bulletin
No Result
View All Result
Home Stock Market News

Top 10 Stocks That Could Make You a Millionaire Over the Next 3 Years

by Global Market Bulletin
June 28, 2026
in Stock Market News
0
Top 10 Stocks That Could Make You a Millionaire Over the Next 3 Years

Top 10 Stocks That Could Make You a Millionaire Over the Next 3 Years

378
SHARES
821
VIEWS
Share on FacebookShare on Twitter

7. Netflix Inc. (NASDAQ:NFLX)

Netflix, Inc. (NASDAQ:NFLX) ranks No. 7 among the Top 10 Stocks That Could Make You a Millionaire Over the Next 3 Years, and the streaming giant’s story is now very different from the one investors followed a decade ago. Trading at $73.81, with the stock up 4.10%, Netflix, Inc. (NASDAQ:NFLX) continues to be one of the most recognizable entertainment stocks, streaming stocks, digital media stocks, and subscription-based business stocks in the world. The company is backed by 144 hedge fund holders, a sign that despite debates over subscriber growth and valuation, institutional investors still view Netflix, Inc. (NASDAQ:NFLX) as a major long-term player. The company built its global reputation by disrupting traditional television, but the market is now judging it on a more mature set of metrics: revenue growth, pricing power, advertising growth, operating margins, free cash flow, and international expansion.

You might also like

Could ARS Pharmaceuticals (SPRY) Disrupt the Emergency Allergy Treatment Market?

Is Lexeo Therapeutics (LXEO) a Good Gene Therapy Stock for Long-Term Growth?

Is Sagimet Biosciences (SGMT) a Promising Biotech Stock to Buy Before Its Next Catalyst?

On June 23, Bernstein maintained a Buy rating on Netflix, Inc. (NASDAQ:NFLX) with a $110 price target, showing continued confidence in the company’s ability to grow despite a more competitive streaming landscape. Earlier on June 18, Citizens reiterated a Market Perform rating on Netflix, Inc. (NASDAQ:NFLX), although it did not disclose a price target. Citizens’ more cautious view was based on the idea that much of Wall Street’s 2027 revenue estimates already reflect the company’s expected price increases. That matters because Netflix, Inc. (NASDAQ:NFLX) has historically been rewarded when it surprised the market with stronger subscriber growth or better-than-expected margins. If price hikes are already priced in, the stock may need a new catalyst to move sharply higher.

Citizens also trimmed its 2027 net subscriber addition estimates, pointing to possible headwinds around user engagement. This is a fair concern because Netflix, Inc. (NASDAQ) is no longer the only serious streaming platform in town. Consumers now have more choices, including platforms backed by media giants, tech companies, and sports-rights owners. However, Citizens still acknowledged Netflix, Inc. (NASDAQ:NFLX)’s structural strengths, especially its scale and distribution. That scale is not a small thing. Netflix, Inc. (NASDAQ:NFLX) has built one of the most powerful global content distribution engines in the entertainment industry, and that gives the company an advantage that smaller streaming rivals may struggle to match. In the streaming business, content matters, but distribution, data, recommendation algorithms, global reach, and pricing discipline also matter.

The more bullish argument came from Bernstein SocGen Group, which reiterated an Outperform rating on Netflix, Inc. (NASDAQ:NFLX) with a $110 price target earlier on June 4. The firm pointed to the factors that previously drove Netflix, Inc. (NASDAQ:NFLX)’s strong investment narrative, including robust subscriber growth, pricing power, and expanding operating margins that flowed through to earnings growth. While that story has lost some momentum, Bernstein does not appear to believe it is broken. Instead, the firm described Netflix, Inc. (NASDAQ:NFLX) as a low-cost, utility-style streaming service with room to grow, especially in non-English-speaking markets that remain underpenetrated. That is an important point for long-term investors. Netflix, Inc. (NASDAQ) may already feel everywhere in the United States, but the international market still provides meaningful runway if the company can localize content, price effectively, and maintain engagement.

Netflix, Inc. (NASDAQ:NFLX) operates a global streaming service offering TV shows, movies, documentaries, interactive content, original programming, and both ad-free and ad-supported viewing plans across devices. The company’s advertising tier could become a more important growth driver over the next three years, especially if Netflix, Inc. (NASDAQ:NFLX) successfully converts its massive audience into higher advertising revenue without damaging the user experience. For investors looking for best stocks to buy now, streaming stocks with upside, entertainment stocks, subscription economy stocks, and long-term growth stocks, Netflix, Inc. (NASDAQ:NFLX) remains a compelling but no-longer-simple story. It is not just a subscriber growth stock anymore. It is becoming a global entertainment utility with pricing power, margin potential, and advertising optionality.

Click next to see the following stock...

Page 4 of 5
Prev1...345Next
Tags: Daily NewsletterEli Lilly and Company (NYSE:LLY)HeadlineNASDAQ:NFLXNASDAQ:TSLANetflix Inc. (NASDAQ:NFLX)NYSE:LLYNYSE:UNHNYSE:VTesla Inc. (NASDAQ:TSLA)Top 10 Stocks That Could Make You a Millionaire Over the Next 3 YearsUnitedHealth Group Incorporated (NYSE:UNH)Visa Inc. (NYSE:V)Yahoo Finance
Share151Tweet95

Global Market Bulletin

Global Market Bulletin is a leading provider of stock market updates, economic news, and personalized investing guides. Our team brings you the latest global financial information to help you make smart investment decisions. About the Editorial Team Our editorial team consists of financial experts and seasoned market analysts who bring decades of experience to our coverage. With a commitment to unbiased reporting, our team ensures that every article is backed by thorough research and delivers accurate financial insights.

Recommended For You

Could ARS Pharmaceuticals (SPRY) Disrupt the Emergency Allergy Treatment Market?

by Global Market Bulletin
July 18, 2026
0
Could ARS Pharmaceuticals (SPRY) Disrupt the Emergency Allergy Treatment Market?

We recently published our article 5 Stocks Under $10 Analysts Believe Could Soar 200%. To read the full story, you can go directly to 10 Stocks Under $10...

Read moreDetails

Is Lexeo Therapeutics (LXEO) a Good Gene Therapy Stock for Long-Term Growth?

by Global Market Bulletin
July 18, 2026
0
Is Lexeo Therapeutics (LXEO) a Good Gene Therapy Stock for Long-Term Growth?

We recently published our article 5 Stocks Under $10 Analysts Believe Could Soar 200%. To read the full story, you can go directly to 10 Stocks Under $10...

Read moreDetails

Is Sagimet Biosciences (SGMT) a Promising Biotech Stock to Buy Before Its Next Catalyst?

by Global Market Bulletin
July 18, 2026
0
Is Sagimet Biosciences (SGMT) a Promising Biotech Stock to Buy Before Its Next Catalyst?

We recently published our article 5 Stocks Under $10 Analysts Believe Could Soar 200%. To read the full story, you can go directly to 10 Stocks Under $10...

Read moreDetails

What Makes SharpLink (SBET) a High-Risk Stock Investors Cannot Ignore?

by Global Market Bulletin
July 18, 2026
0
What Makes SharpLink (SBET) a High-Risk Stock Investors Cannot Ignore?

We recently published our article 5 Stocks Under $10 Analysts Believe Could Soar 200%. To read the full story, you can go directly to 10 Stocks Under $10...

Read moreDetails

Is Omeros (OMER) a Smart Biotech Investment Before Its Next Major Catalyst?

by Global Market Bulletin
July 18, 2026
0
Is Omeros (OMER) a Smart Biotech Investment Before Its Next Major Catalyst?

We recently published our article 5 Stocks Under $10 Analysts Believe Could Soar 200%. To read the full story, you can go directly to 10 Stocks Under $10...

Read moreDetails

Browse by Category

  • CEO Interviews
  • Economy
  • Investing
  • Stock Market News
  • Uncategorized

QUICK LINKS

  • Stock Market News
  • Investing
  • Economy
  • Contact Us
  • About Global Market Bulletin
  • Editorial Policy – Global Market Bulletin
  • Our Editorial Team

RECENT POSTS

  • Could ARS Pharmaceuticals (SPRY) Disrupt the Emergency Allergy Treatment Market?
  • Is Lexeo Therapeutics (LXEO) a Good Gene Therapy Stock for Long-Term Growth?
  • Is Sagimet Biosciences (SGMT) a Promising Biotech Stock to Buy Before Its Next Catalyst?

GET EMAIL MARKET UPDATES

Subscribe to our mailing list to receives daily updates direct to your inbox!
  • Privacy Policy
  • Terms and Conditions

© 2022 Global Market Bulletin. All Rights Reserved.

No Result
View All Result
  • Home
  • Stock Market News
  • Investing
  • Economy

© 2022 Global Market Bulletin. All Rights Reserved.

Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?